Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-PRF vs BOTOX for TMJ Anterior Disc Displacement With Reduction
NCT07385742Completed
- Sponsor
- Suez Canal University
- Start
- Jan 2024
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial in temporomandibular joint internal derangement (TMJID) comparing I-PRF Injection Group with Botulinum Toxin Injection Group (2 arms). Primary endpoints: Visual Analogue Scale Pain Score at 6 months, Joint Sounds (Clicking) Assessment at 6 months and 1 more. Started Jan 2024; status: completed.
02
Drugs
botulinum toxin type Ainjectable platelet-rich fibrin
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT07385742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07385742.